Originally developed for diabetes, GLP-1 medicines are becoming a cultural and commercial infrastructure spanning body image, telehealth and long-term healthcare costs. GLP-1 drugs have moved from specialist medicine to a cultural and commercial force, reshaping conversations about weight, appetite and…
Specialists say taking GLP-1 drugs for a wedding or other event can cause muscle loss, nutritional deficiencies and severe side effects when treatment is not medically supervised. GLP-1 medicines have become one of the most talked-about tools in modern metabolic…
New diabetes and liver guidelines point to earlier, more integrated treatment focused on weight, cardiovascular and kidney risk, and protection from metabolic liver disease. At this year’s European Association for the Study of Diabetes meeting in Milan, metabolic dysfunction-associated steatotic…
Health experts say modest weight loss, regular activity, healthier food choices and routine blood glucose checks can significantly reduce the risk of type 2 diabetes. Keeping a healthy weight remains one of the most effective ways to lower the risk…
November’s annual campaign comes as millions remain unaware they have diabetes or prediabetes, while the condition accounts for a quarter of US healthcare spending. Diabetes Awareness Month returns each November with a familiar purpose: to draw attention to a condition…
Insu Therapeutics has secured a US patent allowance for its buccal delivery platform, but its needle-free insulin and semaglutide treatments remain investigational and require clinical and regulatory approval. Victory Square Technologies said Insu Therapeutics has received a notice of allowance…
A new American College of Lifestyle Medicine consensus statement says group-based consultations could widen access and support behaviour change, while acknowledging that evidence on their effectiveness remains mixed. The American College of Lifestyle Medicine has issued an expert consensus statement…
People with the highest intake of Neu5Gc, a sugar found mainly in beef and lamb, had a 63% higher risk of developing type 2 diabetes, but researchers stressed that the observational findings do not prove cause and effect. New research…
As GLP-1 medicines become a mass-market treatment, evidence of weight regain after withdrawal is sharpening questions about whether they manage symptoms without addressing the environmental and metabolic causes of disease. GLP-1 drugs have moved from niche diabetes treatments to one…
A comprehensive review highlights the critical importance of personalised dietary management in diabetes care, emphasising proper documentation, structured education, and adherence to national guidelines to prevent complications and legal repercussions. Dietary management sits at the centre of diabetes care, not…
